Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

PROcedure related microvascular ACTIVation in long lEsions treated with bioresorbable vascular scaffold versus everolimus-eluting stent implantation (PROACTIVE trial).

Pellicano M, Di Gioia G, Ciccarelli G, Xaplanteris P, Delrue L, Toth GG, Van Durme F, Heyse A, Wyffels E, Vanderheyden M, Bartunek J, De Bruyne B, Barbato E.

EuroIntervention. 2019 May 14. pii: EIJ-D-18-01138. doi: 10.4244/EIJ-D-18-01138. [Epub ahead of print]

2.

Long-Term Patency of Coronary Artery Bypass Grafts After Fractional Flow Reserve-Guided Implantation.

Fournier S, Toth GG, Colaiori I, De Bruyne B, Barbato E.

Circ Cardiovasc Interv. 2019 May;12(5):e007712. doi: 10.1161/CIRCINTERVENTIONS.118.007712. No abstract available.

PMID:
31084238
3.

Endpoint Definitions in Clinical Trials: Consensuses, A Synonym for Dissensuses?

Toth GG, Wijns W.

JACC Cardiovasc Interv. 2019 May 13;12(9):885-889. doi: 10.1016/j.jcin.2019.01.229. Review.

PMID:
31072511
4.

Association of Improvement in Fractional Flow Reserve With Outcomes, Including Symptomatic Relief, After Percutaneous Coronary Intervention.

Fournier S, Ciccarelli G, Toth GG, Milkas A, Xaplanteris P, Tonino PAL, Fearon WF, Pijls NHJ, Barbato E, De Bruyne B.

JAMA Cardiol. 2019 Mar 6. doi: 10.1001/jamacardio.2019.0175. [Epub ahead of print]

PMID:
30840026
5.

Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial.

Lansky A, Wijns W, Xu B, Kelbæk H, van Royen N, Zheng M, Morel MA, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina C, Buszman P, Thiele H, Schächinger V, Baumbach A; TARGET All Comers Investigators.

Lancet. 2018 Sep 29;392(10153):1117-1126. doi: 10.1016/S0140-6736(18)31649-0. Epub 2018 Sep 3.

PMID:
30190206
6.

Study Design of the Graft Patency After FFR-Guided Versus Angiography-Guided CABG Trial (GRAFFITI).

Toth GG, De Bruyne B, Kala P, Ribichini FL, Casselman F, Ramos R, Piroth Z, Fournier S, Van Mieghem C, Penicka M, Mates M, Van Praet F, Degriek I, Barbato E.

J Cardiovasc Transl Res. 2018 Aug;11(4):269-273. doi: 10.1007/s12265-018-9818-9. Epub 2018 Jul 19.

PMID:
30027499
7.

Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery.

Fournier S, Toth GG, De Bruyne B, Johnson NP, Ciccarelli G, Xaplanteris P, Milkas A, Strisciuglio T, Bartunek J, Vanderheyden M, Wyffels E, Casselman F, Van Praet F, Stockman B, Degrieck I, Barbato E.

Circ Cardiovasc Interv. 2018 Jun;11(6):e006368. doi: 10.1161/CIRCINTERVENTIONS.117.006368.

PMID:
29848611
8.

Five-Year Outcomes with PCI Guided by Fractional Flow Reserve.

Xaplanteris P, Fournier S, Pijls NHJ, Fearon WF, Barbato E, Tonino PAL, Engstrøm T, Kääb S, Dambrink JH, Rioufol G, Toth GG, Piroth Z, Witt N, Fröbert O, Kala P, Linke A, Jagic N, Mates M, Mavromatis K, Samady H, Irimpen A, Oldroyd K, Campo G, Rothenbühler M, Jüni P, De Bruyne B; FAME 2 Investigators.

N Engl J Med. 2018 Jul 19;379(3):250-259. doi: 10.1056/NEJMoa1803538. Epub 2018 May 22.

9.

Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation 2 Substudy.

Ciccarelli G, Barbato E, Toth GG, Gahl B, Xaplanteris P, Fournier S, Milkas A, Bartunek J, Vanderheyden M, Pijls N, Tonino P, Fearon WF, Jüni P, De Bruyne B.

Circulation. 2018 Apr 3;137(14):1475-1485. doi: 10.1161/CIRCULATIONAHA.117.028782. Epub 2017 Nov 21. Erratum in: Circulation. 2018 May 29;137(22):e820.

10.

Response by Piroth et al to Letter Regarding Article, "Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation".

Piroth Z, Toth GG, Tonino PAL, Barbato E, Aghlmandi S, Curzen N, Rioufol G, Pijls NHJ, Fearon WF, Jüni P, De Bruyne B.

Circ Cardiovasc Interv. 2017 Oct;10(10). pii: e005973. doi: 10.1161/CIRCINTERVENTIONS.117.005973. No abstract available.

PMID:
29038228
11.

Fractional flow reserve in below the knee arteries with critical limb ischemia and validation against gold-standard morphologic, functional measures and long term clinical outcomes.

Ruzsa Z, Róna S, Tóth GG, Sótonyi P, Bertrand OF, Nemes B, Merkely B, Hüttl K.

Cardiovasc Revasc Med. 2018 Mar;19(2):175-181. doi: 10.1016/j.carrev.2017.07.007. Epub 2017 Jul 18.

12.

Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation.

Piroth Z, Toth GG, Tonino PAL, Barbato E, Aghlmandi S, Curzen N, Rioufol G, Pijls NHJ, Fearon WF, Jüni P, De Bruyne B.

Circ Cardiovasc Interv. 2017 Aug;10(8). pii: e005233. doi: 10.1161/CIRCINTERVENTIONS.116.005233.

13.

Reversed single string technique for coronary bifurcation stenting-First report of case demonstrations in vitro.

Adjedj J, Toth GG, Pellicano M, Wijns W.

Catheter Cardiovasc Interv. 2018 Feb 15;91(3):396-401. doi: 10.1002/ccd.27113. Epub 2017 May 16.

PMID:
28508393
14.

Can Functional Testing for Ischemia and Viability Guide Revascularization?

Mielniczuk LM, Toth GG, Xie JX, De Bruyne B, Shaw LJ, Beanlands RS.

JACC Cardiovasc Imaging. 2017 Mar;10(3):354-364. doi: 10.1016/j.jcmg.2016.12.011. Review.

15.

Computed tomography angiography versus angiography for guiding percutaneous coronary interventions in bifurcation lesions - A prospective randomized pilot study.

Wolny R, Pregowski J, Kruk M, Kepka C, Mintz GS, Toth GG, Debski A, Ciszewski M, Kukula K, Opolski MP, Chmielak Z, Witkowski A.

J Cardiovasc Comput Tomogr. 2017 Mar - Apr;11(2):119-128. doi: 10.1016/j.jcct.2017.01.002. Epub 2017 Jan 17.

PMID:
28117242
16.

Fractional flow reserve to guide and to assess coronary artery bypass grafting.

Pellicano M, De Bruyne B, Toth GG, Casselman F, Wijns W, Barbato E.

Eur Heart J. 2017 Jul 1;38(25):1959-1968. doi: 10.1093/eurheartj/ehw505. Review.

PMID:
28025191
17.

A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve.

Barbato E, Toth GG, Johnson NP, Pijls NH, Fearon WF, Tonino PA, Curzen N, Piroth Z, Rioufol G, Jüni P, De Bruyne B.

J Am Coll Cardiol. 2016 Nov 29;68(21):2247-2255. doi: 10.1016/j.jacc.2016.08.055.

18.

The FAME Trials: Impact on Clinical Decision Making.

Heyndrickx GR, Tóth GG.

Interv Cardiol. 2016 Oct;11(2):116-119. doi: 10.15420/icr.2016:14:3.

19.

Coronary-Artery Bypass Grafting.

Barbato E, Toth GG, De Bruyne B.

N Engl J Med. 2016 Sep 8;375(10):e22. doi: 10.1056/NEJMc1608042. No abstract available.

PMID:
27602684
20.

Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: Evaluations by three-dimensional coronary angiography, optical coherence tomography imaging and fractional flow reserve.

Pyxaras SA, Toth GG, Di Gioia G, Ughi GJ, Tu S, Rusinaru D, Adriaenssens T, Reiber JHC, Leon MB, Bax JJ, Wijns W.

Catheter Cardiovasc Interv. 2017 Jul;90(1):E1-E10. doi: 10.1002/ccd.26777. Epub 2016 Aug 27.

PMID:
27567002

Supplemental Content

Loading ...
Support Center